Russell Frank Company’s Gilead Sciences GILD Stock Holding History

Russell Frank Company’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$158M	Sell	1,719,665 -237,906	-12%	-$21.5M	0.28%	67
2015 Q4	$200M	Sell	1,957,571 -825,905	-30%	-$85.9M	0.35%	57
2015 Q3	$273M	Buy	2,783,476 +480,099	+21%	+$53.3M	0.51%	25
2015 Q2	$270M	Buy	2,303,377 +102,631	+5%	+$11.2M	0.43%	31
2015 Q1	$216M	Sell	2,200,746 -200,437	-8%	-$20.4M	0.4%	36
2014 Q4	$229M	Buy	2,401,183 +855,161	+55%	+$88.4M	0.4%	41
2014 Q3	$165M	Sell	1,546,022 -553,794	-26%	-$54.2M	0.29%	68
2014 Q2	$191M	Sell	2,099,816 -1,053,092	-33%	-$82M	0.33%	59
2014 Q1	$237M	Buy	3,152,908 +312,111	+11%	+$24.5M	0.42%	36
2013 Q4	$229M	Buy	2,840,797 +105,004	+4%	+$7.31M	0.42%	38
2013 Q3	$172M	Buy	2,735,793 +156,601	+6%	+$9.36M	0.3%	71
2013 Q2	$132M	Buy	+2,579,192	New	+$134M	0.24%	86

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Russell Frank Company's GILD Position: Q1 2016 in Review

Russell Frank Company reduced its Gilead Sciences (GILD) stake by 12% in Q1 2016, selling an estimated $21.5M and leaving 1,719,665 shares worth $158M. The position accounts for 0.28% of the portfolio, ranked #67.

Russell Frank Company first reported a position in GILD in Q2 2013 and has held it in 12 quarters since. The position peaked at $273M in Q3 2015. 1,629 funds tracked by Wall St. Rank hold GILD as of Q1 2016.

Russell Frank Company held 1,719,665 shares of Gilead Sciences worth $158M as of Q1 2016.
Russell Frank Company sold 237,906 Gilead Sciences shares in Q1 2016, an estimated $21.5M.
Gilead Sciences made up 0.28% of Russell Frank Company's portfolio in Q1 2016, its #67 holding.
Russell Frank Company first reported a position in Gilead Sciences in Q2 2013 and has held it in 12 quarters since.
Russell Frank Company's Gilead Sciences position peaked at $273M in Q3 2015.
1,629 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.